INSMED Inc INSM

Latest FY: 2025 Healthcare Biotechnology
Market Price $126.72
Market Cap $27.47B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑66.7% YoY
$606.42M
3-Yr CAGR: 35.2%
Net Income ↓-39.7% YoY
-$1.28B
Net Margin: -210.5%
Free Cash Flow ↓-37.1% YoY
-$967.58M
FCF Yield: -3.52%
EPS (Diluted) ↓-15.3% YoY
$-6.42
Basic: $-6.42
Return on Equity Efficiency
-172.8%
ROA: -56.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (INSM)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $-176.3M $-2.85 $-146.7M $-150.9M
FY 2017 $-192.6M -9.3% $-2.89 -1.4% $-159.6M $-162.6M -7.8%
FY 2018 $9.8M $7.4M $-324.3M -68.3% $-4.22 -46.0% $-258.0M $-271.1M -66.7%
FY 2019 $136.5M +1,287.6% $108.8M $-254.3M +21.6% $-3.01 +28.7% $-250.6M $-292.9M -8.1%
FY 2020 $164.4M +20.5% $124.5M $-294.1M -15.6% $-3.01 0.0% $-219.3M $-225.6M +23.0%
FY 2021 $188.5M +14.6% $144.3M $-434.7M -47.8% $-3.88 -28.9% $-363.3M $-370.6M -64.3%
FY 2022 $245.4M +30.2% $190.2M $-481.5M -10.8% $-3.91 -0.8% $-400.4M $-410.3M -10.7%
FY 2023 $305.2M +24.4% $223.5M $-749.6M -55.7% $-5.34 -36.6% $-536.2M $-549.5M -33.9%
FY 2024 $363.7M +19.2% $278.0M $-913.8M -21.9% $-5.57 -4.3% $-683.9M $-705.8M -28.4%
FY 2025 $606.4M +66.7% $483.5M $-1,276.8M -39.7% $-6.42 -15.3% $-935.0M $-967.6M -37.1%
$

Valuation

Market Price $126.72
Market Cap $27.47B
Enterprise Value $27.50B
P/E Ratio N/A
P/B Ratio 37.17
FCF Yield -3.52%
Dividend Yield N/A
Shares Outstanding 216,752,500
%

Profitability & Margins

Gross Margin 79.73%
Operating Margin -205.59%
Net Margin -210.54%
Return on Equity (ROE) -172.78%
Return on Assets (ROA) -56.38%
Asset Turnover 0.27x
Revenue 3-Yr CAGR 35.20%
🛡️

Financial Health & Liquidity

Current Ratio 3.83
Cash Ratio 1.09
Debt / Equity 0.732
Debt / Assets 0.239
Cash & Equivalents $510.44M
Total Debt $540.96M
Book Value / Share $3.41
💧

Cash Flow Efficiency

Operating Cash Flow -$935.01M
Capital Expenditures (CapEx) $32.56M
Free Cash Flow -$967.58M
OCF / Revenue -154.19%
FCF / Revenue -159.55%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-6.42
EPS (Basic) $-6.42
Dividends / Share N/A
Book Value / Share $3.41
EPS YoY Growth -15.26%
🏛️

Balance Sheet (FY 2025)

Total Assets $2.26B
Total Liabilities $1.53B
Stockholders' Equity $738.98M
Current Assets $1.79B
Current Liabilities $468.87M